US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

300.70

+4.391.48%

Post-market: 302.301.60+0.53%19:59 EDT

Volume:214.27K

Turnover:63.36M

Market Cap:578.69M

PE:- -

High:301.50

Open:291.05

Low:289.32

Close:296.31

52wk High:341.93

52wk Low:71.88

Shares:1.92M

Float Shares:1.92M

Volume Ratio:0.59

T/O Rate:11.13%

Dividend:1.01

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

BioSyent Maintains Quarterly Dividend as Specialty Healthcare Growth Continues

Viemed Healthcare Updates Investor Deck, Highlights Growth Strategy

Ensign Group Expands Long-Term Credit Facility for Growth

Health Care Down as Moderna Gives Back Some Gains - Health Care Roundup

Health Care Roundup: Market Talk

Press Release: Joerns Healthcare Completes Strategic Portfolio Realignment Through Sale of Netherlands Business

Aveanna announces offering of 15M shares of common stock for holders

Sector Update: Healthcare

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Decibel Cannabis Company (OtherDBCCF) and SELLAS Life Sciences Group (SLS)

Sector Update: Healthcare Stocks Fall Thursday Afternoon

MT Newswires Live

Health Care Roundup: Market Talk

Lifeward: Buy Rating Reiterated as Partner-Led Growth Strategy Drives Momentum; 12-Month Price Target Maintained at $10

Analysts Conflicted on These Healthcare Names: IDEAYA Biosciences (IDYA) and Definitive Healthcare Corp (DH)

Ultragenyx Pharmaceutical (RARE) Stock Jumps 9% on Accelerated FDA Approval

Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT) and Viridian Therapeutics (VRDN)

Rhelion’s Filament Health to Harness FDA-Authorized AI Imaging in Psilocybin Alzheimer’s Trial Design

Teva (TEVA) Wins FDA Priority Review For Pediatric Tourette Drug Candidate

Simply Wall St.

Regeneron’s Pasatru granted FDA approval for FOP

Sector Update: Healthcare

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Ultragenyx Pharmaceutical (RARE) and Cytokinetics (CYTK)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/LABU/news?page=18"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":300.7,"timestamp":1788292800000,"preClose":296.31,"halted":0,"volume":214265,"hourTrading":{"tag":"盘后","latestPrice":302.3,"preClose":300.7,"latestTime":"19:59 EDT","volume":2272,"amount":684736.992,"timestamp":1788307173491,"change":1.6,"changeRate":0.005321,"amplitude":0.005321},"delay":0,"changeRate":0.014815564780128873,"floatShares":1924486,"shares":1924486,"eps":0,"marketStatus":"Not Yet Opened","change":4.39,"latestTime":"09-01 16:00:00 EDT","open":291.05,"high":301.5,"low":289.32,"amount":63362413.66025,"amplitude":0.041106,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":296.31,"sharesOutstanding":3074486,"nav":296.788,"aum":571163817.07,"dividendRate":0.003351,"bidAskSpread":0.00268,"preHourTrading":{"tag":"盘前","latestPrice":287.9,"preClose":296.31,"latestTime":"09:25 EDT","volume":3856,"amount":1113924.82752,"timestamp":1788269101054,"change":-8.41,"changeRate":-0.028382,"amplitude":0.034741},"postHourTrading":{"tag":"盘后","latestPrice":302.3,"preClose":300.7,"latestTime":"19:59 EDT","volume":2272,"amount":684736.992,"timestamp":1788307173491,"change":1.6,"changeRate":0.005321,"amplitude":0.005321},"volumeRatio":0.594455,"impliedVol":0.9266,"impliedVolPercentile":0.5794},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.594455,"shares":1924486,"dividePrice":1.0075,"high":301.5,"amplitude":0.041106,"preClose":296.31,"low":289.32,"week52Low":71.88,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":300.7,"eps":0,"divideRate":0.003351,"volume":214265,"delay":0,"ttmEps":0,"open":291.05,"prevYearClose":159.39,"prevWeekClose":295.76,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":335.54,"twentyDayClose":249.47,"sixtyDayClose":160.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:18,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661237005","title":"BioSyent Maintains Quarterly Dividend as Specialty Healthcare Growth Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=2661237005","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661237005?lang=en_us&edition=fundamental","pubTime":"2026-08-21 05:41","pubTimestamp":1787262090,"startTime":"0","endTime":"0","summary":"Biosyent ( ($TSE:RX) ) just unveiled an update. BioSyent Inc., a specialty healthcare company listed on the TSX Venture Exchange, markets and distr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biosyent-maintains-quarterly-dividend-as-specialty-healthcare-growth-continues?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biosyent-maintains-quarterly-dividend-as-specialty-healthcare-growth-continues?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4550","XBI","LABU","NOBL","BK4137","HCSG","BK4581","LU0128526141.USD","TCAF","VHT","XLV","LU0029874061.USD","CGCV","IXJ","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661923700","title":"Viemed Healthcare Updates Investor Deck, Highlights Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2661923700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661923700?lang=en_us&edition=fundamental","pubTime":"2026-08-21 05:28","pubTimestamp":1787261321,"startTime":"0","endTime":"0","summary":"Viemed Healthcare ( ($VMD) ) has issued an update. Viemed Healthcare has released an updated investor deck dated August 2026, which it plans to use...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/viemed-healthcare-updates-investor-deck-highlights-growth-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/viemed-healthcare-updates-investor-deck-highlights-growth-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4585","LU0029874061.USD","HCSG","XLV","BK4137","BK4588","BK4581","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661468237","title":"Ensign Group Expands Long-Term Credit Facility for Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661468237","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661468237?lang=en_us&edition=fundamental","pubTime":"2026-08-21 05:11","pubTimestamp":1787260292,"startTime":"0","endTime":"0","summary":"The Ensign Group ( ($ENSG) ) has provided an announcement. On August 19, 2026, The Ensign Group, Inc. and Standard Bearer Healthcare REIT, Inc. ent...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ensign-group-expands-long-term-credit-facility-for-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ensign-group-expands-long-term-credit-facility-for-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RJMG","YLDW","BK4585","LU0054578231.USD","BPRE","XBI","IVRA","LABU","PSCF","XLV","BK4581","BK4185","MDIV","REIT","ENSG","LU0240877869.USD","DFRA","IQRA","RNTY","BK4588","LU0240878834.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661237186","title":"Health Care Down as Moderna Gives Back Some Gains - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2661237186","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661237186?lang=en_us&edition=fundamental","pubTime":"2026-08-21 05:11","pubTimestamp":1787260260,"startTime":"0","endTime":"0","summary":"Health-care companies fell as euphoria about a breakthrough in RNA-based medicine faded.Moderna shed almost one quarter of its value, giving back a chunk of the gains associated with Wednesday's disclosure of promising data on a cancer treatment. Moderna and Merck's jointly developed personalized cancer vaccine had stopped melanoma cancer from coming back or spreading in patients. The personalized nature of the vaccine and the relatively low occurrence of the melanoma strain of skin cancer could limit commercial potential.For 2027, employers may be facing the biggest health-insurance increase in at least two decades.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","LABU","XLV","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661237318","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2661237318","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661237318?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:50","pubTimestamp":1787259000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0824 ET - Moderna shares surging 176% on Wednesday may have been","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","BK4585","LABU","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661237382","title":"Press Release: Joerns Healthcare Completes Strategic Portfolio Realignment Through Sale of Netherlands Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2661237382","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661237382?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:49","pubTimestamp":1787258940,"startTime":"0","endTime":"0","summary":"Transaction sharpens Joerns' focus on North American growth while ensuring continued product access and support for customers across the Benelux regionCHARLOTTE, N.C., Aug. 20, 2026 /PRNewswire/ -- Jo","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4585","BK4588","BK4137","XLV","LU0029874061.USD","BK4581","BK4022","BK4232","LU0128526141.USD","HCSG","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232952","title":"Aveanna announces offering of 15M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232952","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232952?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:15","pubTimestamp":1787256955,"startTime":"0","endTime":"0","summary":"Aveanna (AVAH) Healthcare Holdings announced that certain selling stockholders, including affiliates of J.H. Whitney Equity Partners VII, and certa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aveanna-announces-offering-of-15m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aveanna-announces-offering-of-15m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","LABU","AVAH","BK4588","BK4585","BK4196","BK4539","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661025231","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2661025231","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661025231?lang=en_us&edition=fundamental","pubTime":"2026-08-21 03:16","pubTimestamp":1787253378,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index decreasing 0.9% and the State Street Health Care Select Sector SPDR ETF  shedding 1.4%.The iShares Biotechnology ETF  fell 2.4%.In corporate news, Moderna  shares fell 22% following a 177% jump at the close of the previous trading session. The drugmaker and Merck  announced positive topline results from a late-stage trial of an experimental skin cancer treatment on Wednesday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","BK4534","XBI","BK4551","IDNA","WDNA","MRNX","BK4139","IBB","XLV","LGHT","BK4501","LABU","MRNA","GNOM","BK4585","BK4588","MRNY","BK4532","BK4581","BK4548","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661231334","title":"Analysts Offer Insights on Healthcare Companies: Decibel Cannabis Company (OtherDBCCF) and SELLAS Life Sciences Group (SLS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661231334","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661231334?lang=en_us&edition=fundamental","pubTime":"2026-08-21 02:10","pubTimestamp":1787249407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Decibel Cannabis Company (DBCCF) and SELLAS Life Sci...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-decibel-cannabis-company-otherdbccf-and-sellas-life-sciences-group-sls-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-decibel-cannabis-company-otherdbccf-and-sellas-life-sciences-group-sls-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4581","HCSG","LU0128526141.USD","XLV","XBI","YOLO","CNBS","MSOS","MSOX","SLS","BK4139","WEED","MJ","BK4137","BK4588","BK4585","BK4007","DBCCF","LABU","TOKE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661239913","title":"Sector Update: Healthcare Stocks Fall Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2661239913","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661239913?lang=en_us&edition=fundamental","pubTime":"2026-08-21 01:43","pubTimestamp":1787247786,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index decreasing 0.7% and the State Street Health Care Select Sector SPDR ETF  shedding 1.1%.The iShares Biotechnology ETF  fell 2.7%.In corporate news, Merck's  strong momentum continues, driven by better-than-expected cancer vaccine data, but valuation now fully reflects the upside, RBC Capital Markets said in a note. RBC downgraded Merck to sector perform from outperform, and raised its price target to $150 from $142. Merck shares were down 0.5%.Abbott Laboratories  signed a multiyear collaboration deal with Avricore Health's HealthTab unit for the supply and distribution of its point-of-care testing products through the HealthTab platform in the UK, Avricore Health said. Abbott shares were down 0.1%.OSR Health  shares were down past 25%, a day after the company said it received a notice from Nasdaq that its shares would be delisted from the stock exchange on Aug. 26 for failing to regain compliance with the min","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BMED","LU0882574055.USD","LU1989772840.SGD","PAWZ","SG9999002232.USD","LU2468319806.SGD","VHT","LU1941712348.USD","LU2089984988.USD","RXL","LU0124676726.USD","LU0238689110.USD","LU0432979614.USD","LU1585245621.USD","LU0823416689.USD","LU2361045086.USD","BK4568","LU0058720904.USD","IE00B2B36J28.USD","LU1691799644.USD","LU1430594728.SGD","SG9999014567.USD","IXJ","LU1989763427.SGD","LU2125154935.USD","LU1983299246.USD","IHI","IE00B1BXHZ80.USD","LU0208291251.USD","LU0320765489.SGD","LU1721429741.USD","LU0130517989.USD","SG9999015341.SGD","LU0203345920.USD","LU0203347892.USD","SG9999002224.SGD","LU2211815571.USD","LU1061106388.HKD","LU2360032135.SGD","LU1929549753.HKD","LU2361044865.SGD","BK4559","BK4139","LU0861579265.USD","TRUH","LU0266013472.USD","LU1093756325.SGD","BK4550","LU0289739699.SGD","LU0965508806.USD","IE00BLSP4239.USD","LU0265550359.USD","LU1162221912.USD","FHLC","HRTS","LU2361044949.HKD","LU2491050071.SGD","LU0234572021.USD","LU1917777945.USD","LU1093756168.USD","LU1291159041.SGD","LU1989772923.USD","MRK","SG9999014542.SGD","IE00B4R5TH58.HKD","LU0980610538.SGD","SG9999014575.USD","LU0114720955.EUR","LU2433249047.HKD","LU1934455863.HKD","SGXZ57979304.SGD","LU1066051225.USD","LU1023059063.AUD","IE00BSNM7G36.USD","LU0320765646.SGD","LU0122379950.USD","LU1035773651.USD","LU0211331839.USD","LU1116320901.HKD","SG9999015358.SGD","LU0477156953.USD","LU1914381329.SGD","LU2125154778.USD","BK4585","LU0965509101.SGD","LU1934455194.USD","LU1066051498.USD","LU0859254822.USD","IE00BFTCPJ56.SGD","BK4588","LU1923622614.USD","LU2237957811.SGD","LU1037948897.HKD","XBI","LU0170899867.USD","LABU","LU2133065610.SGD","LU0942090050.USD","GDOC","BK4581","LU1057294990.SGD","LU2461242641.AUD","LU0106261372.USD","LU0265550946.USD","PJP","IHE","LU1069347547.HKD","OSRH","LU1941712264.USD","IE00BN8TJ469.HKD","LU2112291526.USD","TMED","LU1571399168.USD","LU0868494708.USD","ABT","IE0009355771.USD","PPH","BK4082","IE000M9KFDE8.USD","LU0965509010.AUD","SG9999014559.SGD","SGXZ23171101.USD","LU2491049909.HKD","LU2023250843.SGD","LU2125909593.SGD","LU1989771016.USD","BK4533","XLV","LU2237957902.USD","LU1066053197.SGD","BK4504","LU0965509283.SGD","LU1116320737.USD","LU0689626769.HKD","SG9999001176.SGD","LU2357627491.SGD","LU0648001328.SGD","IBB","LU0098860793.USD","BK4007","LU0130102774.USD","LU2324357040.USD","BK4516","IE00BJJMRZ35.SGD","BK4566","LU2125909247.SGD","LU1699723380.USD","SG9999013999.USD","LU1721429402.USD","LU1934455277.USD","LU1037948541.HKD","BK4534","SG9999001176.USD","LU0868494617.USD","BK4592","IE00BJT1NW94.SGD","IE0002141913.USD","SG9999004303.SGD","LU1974910355.USD","LU1066051811.HKD","LU2491050154.USD","SG9999001440.SGD","LU2106854487.HKD","LU1201861249.SGD","IYH","LU0985320562.USD","IE00BBT3K403.USD","LU1989763690.USD","JDOC","SGXZ41872573.SGD","LU0070302665.USD","LU2023250504.SGD","FTXH","IE00BLSP4452.SGD","LU0006306889.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661368602","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2661368602","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661368602?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:20","pubTimestamp":1787242800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0824 ET - Moderna shares surging 176% on Wednesday may have been","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588","XBI","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660233981","title":"Lifeward: Buy Rating Reiterated as Partner-Led Growth Strategy Drives Momentum; 12-Month Price Target Maintained at $10","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233981","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233981?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:55","pubTimestamp":1787237728,"startTime":"0","endTime":"0","summary":"Lifeward, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Swayampakula Ramakanth from H.C. Wainwright maintain...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/lifeward-buy-rating-reiterated-as-partner-led-growth-strategy-drives-momentum-12-month-price-target-maintained-at-10-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/lifeward-buy-rating-reiterated-as-partner-led-growth-strategy-drives-momentum-12-month-price-target-maintained-at-10-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4581","XBI","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660801452","title":"Analysts Conflicted on These Healthcare Names: IDEAYA Biosciences (IDYA) and Definitive Healthcare Corp (DH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660801452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660801452?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:50","pubTimestamp":1787233811,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on IDEAYA Biosciences (IDYA) and Definitive Healthcare Corp (DH). ID...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ideaya-biosciences-idya-and-definitive-healthcare-corp-dh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ideaya-biosciences-idya-and-definitive-healthcare-corp-dh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4139","BK4167","BK4581","LABU","BK4585","XBI","DH","IDYA","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660280813","title":"Ultragenyx Pharmaceutical (RARE) Stock Jumps 9% on Accelerated FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2660280813","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660280813?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:43","pubTimestamp":1787233424,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical stock rallied 8.99% on Thursday after the FDA granted Ultragenyx Pharmaceutical’s GENGLYCOS accelerated approval.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ultragenyx-pharmaceutical-rare-stock-jumps-9-on-accelerated-fda-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ultragenyx-pharmaceutical-rare-stock-jumps-9-on-accelerated-fda-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4139","RARE","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287027","title":"Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT) and Viridian Therapeutics (VRDN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287027","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287027?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:40","pubTimestamp":1787233213,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Health Catalyst (HCAT) and Viridian Therapeutics (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-health-catalyst-hcat-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-health-catalyst-hcat-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0128526141.USD","BK4581","LABU","BK4137","BK4167","BK4585","HCSG","LU0029874061.USD","XBI","VRDN","BK4588","XLV","HCAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660428705","title":"Rhelion’s Filament Health to Harness FDA-Authorized AI Imaging in Psilocybin Alzheimer’s Trial Design","url":"https://stock-news.laohu8.com/highlight/detail?id=2660428705","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660428705?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:38","pubTimestamp":1787233139,"startTime":"0","endTime":"0","summary":"Red Light Holland ( ($TSE:RHEL) ) has issued an update. Rhelion Life Sciences’ subsidiary Filament Health has signed a non-binding letter of intent...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rhelions-filament-health-to-harness-fda-authorized-ai-imaging-in-psilocybin-alzheimers-trial-design?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rhelions-filament-health-to-harness-fda-authorized-ai-imaging-in-psilocybin-alzheimers-trial-design?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIX","CHAT","BK4588","BK4585","QTOC","LABU","AIPO","ARTY","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660633238","title":"Teva (TEVA) Wins FDA Priority Review For Pediatric Tourette Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2660633238","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660633238?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:30","pubTimestamp":1787232636,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries (NYSE:TEVA) announced that the U.S. FDA has accepted its New Drug Application for ecopipam for pediatric Tourette syndrome with Priority Review status.\nEcopipam is described by Teva as a first in class therapy candidate targeting children and adolescents with Tourette syndrome, an area where no new treatments have been approved in over a decade.\nThe filing is backed by positive late stage clinical trial data and adds another potential branded medicine to Teva's...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/308047-main-header/1585187365850","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/308047-main-header/1585187365850"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-teva/teva-pharmaceutical-industries/news/teva-teva-wins-fda-priority-review-for-pediatric-tourette-dr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-teva/teva-pharmaceutical-industries/news/teva-teva-wins-fda-priority-review-for-pediatric-tourette-dr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","BK4596","BK4584","BK4557","BK4585","BK4588","LU2324357040.USD","BK4566","LABU","TEVA","LU1983299246.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287604","title":"Regeneron’s Pasatru granted FDA approval for FOP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287604","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287604?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:20","pubTimestamp":1787232025,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has approved Pasatru to reduce new heterotopic ossification and reduce clinician-assessed disease flare-ups i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","PINK","LFSC","BK4588","BMED","TECB","SYNB","FRTY","MEDI","PSCH","BBP","GDOC","IDNA","XLVX","BK4585","TBXU","MRNY","IEIH","IYH","NVIB","LABU","RSPH","IBB","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282499","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282499","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282499?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:01","pubTimestamp":1787230902,"startTime":"0","endTime":"0","summary":"Healthcare stocks were leaning lower pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF  down 0.5% and the iShares Biotechnology ETF  declining by 1%.Ultragenyx Pharmaceutical  has received accelerated approval from the US Food and Drug Administration for Genglycos to treat glycogen storage disease type Ia, a rare genetic metabolic disorder due to an enzyme deficiency, the drugmaker said. Ultragenyx Pharmaceutical shares were up more than 6% premarket.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","LU0128526141.USD","BK4581","RARE","BK4585","HCSG","XLV","XBI","BK4137","IBB","BK4588","BK4139","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282761","title":"Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Ultragenyx Pharmaceutical (RARE) and Cytokinetics (CYTK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282761","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282761?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:00","pubTimestamp":1787230821,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Medtronic (MDT), Ultragenyx Pharmaceutical (RARE) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medtronic-mdt-ultragenyx-pharmaceutical-rare-and-cytokinetics-cytk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medtronic-mdt-ultragenyx-pharmaceutical-rare-and-cytokinetics-cytk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LU0006306889.USD","BK4588","BK4533","IE00BQXX3F31.USD","LU0106261372.USD","LU1244550577.SGD","LU0320765489.SGD","HCSG","LU2023251221.USD","BK4505","BK4139","LU0211331839.USD","LU0211326755.USD","BK4581","LU1023059063.AUD","LU0314106906.USD","LU1116320901.HKD","XBI","LU0029874061.USD","LU0432979614.USD","IE00B3T34201.USD","IE00BFXG1179.USD","LU2089284900.SGD","RARE","IE00BVYPNW00.USD","LU1983299246.USD","LU1989764664.SGD","LU0211326839.USD","LU2468319806.SGD","LU2089283258.USD","LU1506573853.SGD","IE00B42XCP33.USD","IE00BQXX3D17.EUR","LU0158827948.USD","LU2271345857.HKD","BK4137","BK4082","BK4566","IE00BDGV0183.EUR","LU0496365809.HKD","IE00BGHQF631.EUR","LABU","LU0265550946.USD","LU1571399168.USD","LU1989771016.USD","LU2112291526.USD","CYTK","MDT","LU0976567544.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":18,"totalSize":412,"code":"91000000","status":"200"}]}}